Influence of Pentoxifylline on Muscle Tissue Oxygen Tension (pO2) of Patients with Intermittent Claudication Before and After Pedal Ergometer Exercise
- Is cilostazol more effective than pentoxifylline in the treatment of symptoms of intermittent claudication? Weismantel, David // Journal of Family Practice;Feb2001, Vol. 50 Issue 2, p181
This article presents a study which examined the effectiveness of cilostazol over pentoxifylline in the treatment of symptoms of intermittent claudication. The study population is composed of patients with stable moderate to severe symptoms of intermittent claudication and confirmed peripheral...
- Effects of Cilostazol and Pentoxifylline on Forearm Reactive Hyperemia Response, Lipid Profile, Oxidative Stress, and Inflammatory Markers in Patients With Intermittent Claudication. de Albuquerque, Renato Maranhão; Virgini-Magalhães, Carlos Eduardo; Sicuro, Fernando Lencastre; Bottino, Daniel Alexandre; Bouskela, Eliete // Angiology;Oct/Nov2008, Vol. 59 Issue 5, p549
Peripheral arterial disease may lead to lower limb claudication and increased risk of systemic vascular dysfunction. In this article, the authors have investigated the peripheral vascular dysfunction evaluating forearm blood flow using venous occlusion plethysmography, lipid profile, and...
- Cilostazol cost effective for intermittent claudication in the UK. // PharmacoEconomics & Outcomes News;7/2/2005, Issue 481, p5
Provides information on research regarding the use of cilostazol in patients with intermittent claudication. Cost effectiveness of the drug; Improvement in maximal walking distance of patients treated with cilostazol; Treatment costs for cilostazol compared with naftidrofuryl and pentoxifylline.
- Pentoxifylline and Intermittent Claudication. Spittell, John A. // Annals of Internal Medicine;Jan85, Vol. 102 Issue 1, p126
Reports that the U.S. Food and Drug Administration approved as of January 1985, the use of pentoxifylline, a methylxanthine with vasoactive properties for the symptomatic treatment of intermittent claudication due to chronic occlusive peripheral arterial disease. Recommended dose; Alternative...
- Effects of Pentoxifylline on Severe Intermittent Claudication. Reich, Theobald; Gilings, Dennis // Angiology;Sep1987, Vol. 38 Issue 9, p651
Pentoxifylline has been shown to improve treadmill walking distances under blinded, controlled conditions in patients with intermittent claudication. From the pooled data of a blinded, controlled, randomized, multicenter trial, the data from all enrolled patients with severe claudication (< 70 m...
- Efficacy and Safety of Pentoxifylline in Geriatric Patients with Intermittent Claudication. Crowder, John E.; Cohn, Jay B.; Savitsky, J. Philip; Morgan, DeAnn L.; Slywka, Joseph; Cobert, Barton L.; Hryniewicki, Stephen W.; Piccirillo, Ronald T.; Wilcox, Charles S. // Angiology;Sep1989, Vol. 40 Issue 9, p795
The effects of pentoxifylline on intermittent claudication were evaluated at a dose of 1200 mg/day in an open-label twelve-week study on geriatric patients with chronic occlusive arterial disease (COAD). Standardized treadmill testing and clinical signs and symptoms of COAD were followed up...
- Evaluation of pentoxifylline effect in treatment of ankylosis spondylitis patients referred to Rasool-e- Akram Hospital. Shirani, Fatemeh; Mehdi Sebt Rozati, Seyed // Razi Journal of Medical Sciences;Aug/Sep2011, Vol. 18 Issue 87, p8
Background: Ankylosing spondylitis (AS) is a spondyloarthropathy of unknown etiology, with widespread effect on axial and peripheral skeleton. The aim of this study was determination of pentoxifylline effect on Bath Ankylosing spondylitis Disease Activity Index (BASDAI) of uncontrolled AS...
- Efficacy of Cilostazol for Intermittent Claudication. Apgar, Barbara // American Family Physician;2/15/2000, Vol. 61 Issue 4, p1124
Discusses the study `A New Pharmacological Treatment for Intermittent Claudication: Results of a Randomized, Multicenter Trial,' by H.G. Beebe and colleagues published in the September 27, 1999 issue of the `Archives of Internal Medicine.'
- CORRESPONDENCE. Dawber, Rodney; MacGowan, Alastair P.; Johnston, Peter W.; Thomson, Angus W.; Harris, P.F.; Elwood, J. Mark; Longhore, H.J.A.; Dunn, Ailsa M; Buckley, Brendan M.; Axford, J.S.; Berry, H.; Stewart, Gordon T.; Williams, Gareth; Pickup, John; Petitti, Diana B.; Beverly, Michael C.; Evans, Michael J.; Bone, P.J. // British Medical Journal (Clinical Research Edition);7/19/1986, Vol. 293 Issue 6540, p201
Focuses on health related issues in Europe. Association of hyponatremia with non-steroidal anti-inflammatory drugs; Alteration of thyroid function following treatment with fenoprofen; Derivation of transcutaneous oxygen tension during exercise in patients with claudication.